The Effectiveness of Radial ESWT on Upper Trapezius Mtrps

NCT ID: NCT05187468

Last Updated: 2022-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2020-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looked after the effectiveness of radial ESWT on upper trapezius mtrps. There were three intervention groups which recieved either ESWT or standard care. VAS, PPT, Neck ROM and Cervical functionality were the main outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was a randomized controlled trial consisted of three intervention groups. Two of them recieved ESWT with different parameters in each group, while the third one was standard care recieving Ultrasound therapy, Therapeutic massage and Heat packs Participants were divided randomly into the three groups. Participants were blind to the group allocated and also the therapist and outcome investigator were blind.

The participants recieved three weekly sessions. The evaluation took place before therapy, after each session and one month after last session.

The outcome measures was the pain intensity with VAS, the pain tolerance to pressure by an algometer device, the range of motion of neck measured by electronic goniometer and and functionality of neck measured by the Northwick Park Neck Pain

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome Myofascial Trigger Point Pain Upper Trapezius Trigger Points

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESWT 1

Extracorporeal Shockwave Therapy 1000 pulses, 60 mJ, 10 Hz

Group Type EXPERIMENTAL

Extracorporeal Shockwave Therapy

Intervention Type DEVICE

1000 pulses at 60 mj, 10 Hz

ESWT 2

Extracorporeal Shockwave Therapy 2000 pulses, 60 mJ, 10 Hz

Group Type EXPERIMENTAL

Extracorporeal Shockwave Therapy

Intervention Type DEVICE

2000 pulses at 60 mj, 10 Hz

Ultrasound therapy, Massage, Heat Pack

10 Min massage 5 min US therapy 10 min Heat pack

Group Type ACTIVE_COMPARATOR

Ultrasound therapy, Massage, Heat pack

Intervention Type DEVICE

Ultrasound therapy 5 min, 1,2W/cm2, 10 min Massage, 10 min heat pack

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal Shockwave Therapy

1000 pulses at 60 mj, 10 Hz

Intervention Type DEVICE

Extracorporeal Shockwave Therapy

2000 pulses at 60 mj, 10 Hz

Intervention Type DEVICE

Ultrasound therapy, Massage, Heat pack

Ultrasound therapy 5 min, 1,2W/cm2, 10 min Massage, 10 min heat pack

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ESWT rSWT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pain between shoulder and neck on upper trapezius muscle
* Three out of five of Travel and Simons criteria for myofascial trigger points

Exclusion Criteria

* Fibromyalgia diagnosis
* Systemic diseases diagnosis,
* Pacemaker, under 18,
* Any kind of cervical disorder or surgery,
* Mental disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European University Cyprus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rentzias Panagiotis

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

European University Cyprus

Nicosia, , Cyprus

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Cyprus

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EuropeanUC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.